3-Oxo-3-{2,5,7-triazatricyclo[6.4.0.0,2,6]dodeca-1(12),6,8,10-tetraen-5-yl}propanenitrile

Catalog No. :
ACOKWX869
CAS No. :
565165-42-6
Molecular Formula :
C12H10N4O
Molecular Weight :
226.24

IUPAC Name:3-(2,3-dihydro-1H-benzo[d]imidazo[1,2-a]imidazol-1-yl)-3-oxopropanenitrile

3-Oxo-3-{2,5,7-triazatricyclo[6.4.0.0,2,6]dodeca-1(12),6,8,10-tetraen-5-yl}propanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$101.00Login to see priceInquiryInquiry
250mg95%$133.00Login to see priceInquiryInquiry
1g95%$339.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Oxo-3-{2,5,7-triazatricyclo[6.4.0.0,2,6]dodeca-1(12),6,8,10-tetraen-5-yl}propanenitrile
IUPAC Name3-(2,3-dihydro-1H-benzo[d]imidazo[1,2-a]imidazol-1-yl)-3-oxopropanenitrile
MDL No.MFCD03964655
Molecular FormulaC12H10N4O
Molecular Weight226.24
SMILESN#CCC(N1CCN2C3=CC=CC=C3N=C12)=O
InChI KeyDHFPOUMOBYUWJQ-UHFFFAOYSA-N
Synonym1H-Imidazo[1,2-a]benzimidazole-1-propanenitrile, 2,3-dihydro-β-oxo-;3-Oxo-3-{2,5,7-triazatricyclo[6.4.0.0,2,6]dodeca-1(12),6,8,10-tetraen-5-yl}propanenitrile
CAS No.565165-42-6

Synthetic Route by SureRoute

1. ACOKWX869 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWZVY768 route compound structure diagram
    ACWZVY76824134-26-7 In Stock
  4. Then
  5. ACOKWX869 route product structure diagram
    ACOKWX869565165-42-6
Inquiry

2. ACOKWX869 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMCAP915 route compound structure diagram
    ACMCAP9151071-36-9 In Stock
  2. Plus
  3. ACWZVY768 route compound structure diagram
    ACWZVY76824134-26-7 In Stock
  4. Then
  5. ACOKWX869 route product structure diagram
    ACOKWX869565165-42-6
Inquiry

Comments (0)